CoChat

ESC Study Group of Sports Cardiology Position Paper on adverse cardiovascular effects of doping in athletes

Open access
Deligiannis, Asterios, Björnstad, Hans, Carre, Francois, Heidbüchel, Hein, Kouidi, Evangelia, Panhuyzen-Goedkoop, Nicole M., Pigozzi, Fabio, Schänzer, Wilhelm, Vanhees, Luc, on behalf of the ESC Study Group of Sports Cardiology · 2006 · European Journal of Cardiovascular Prevention & Rehabilitation
Cited by 117

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

The use of doping substances and methods is extensive not only among elite athletes, but also among amateur and recreational athletes. Many types of drugs are used by athletes to enhance performance, to reduce anxiety, to increase muscle mass, to reduce weight or to mask the use of other drugs during testing. However, the abuse of doping substances and methods has been associated with the occurrence of numerous health side-effects. The adverse effects depend on the type of the consumed drug, as well as the amount and duration of intake and the sensitivity of the body, since there is a large inter-individual variability in responses to a drug. Usually the doses used in sports are much higher than those used for therapeutic purposes and the use of several drugs in combination is frequent, leading to higher risk of side-effects. Among biomedical side-effects of doping, the cardiovascular ones are the most deleterious. Myocardial infarction, hyperlipidemia, hypertension, thrombosis, arrythmogenesis, heart failure and sudden cardiac death have been noted following drug abuse. This paper reviews the literature on the adverse cardiovascular effects after abuse of prohibited substances and methods in athletes, aiming to inform physicians, trainers and athletes and to discourage individuals from using drugs during sports.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.hjr.0000224482.95597.7a

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 117

Metadata

Authors
Deligiannis, A., Björnstad, H., Carre, F., Heidbüchel, H., Kouidi, E., Panhuyzen-Goedkoop, N. M., Pigozzi, F., Schänzer, W., Vanhees, L., & on behalf of the ESC Study Group of Sports Cardiology
Venue
European Journal of Cardiovascular Prevention & Rehabilitation
Published
2006-10
Volume
13
Issue
5
Pages
687-694
ISSN
1741-8267 (ISSN-L)
OpenAlex
W2158034785
Cited by
117
References
2
FWCI
18.44
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ESC Study Group of Sports Cardiology Position Paper on adverse cardiovascular effects of doping in athletes. https://app.cochat.ai/papers/10.1097/01.hjr.0000224482.95597.7a
The paper
Deligiannis, A., Björnstad, H., Carre, F., Heidbüchel, H., Kouidi, E., Panhuyzen-Goedkoop, N. M., Pigozzi, F., Schänzer, W., Vanhees, L., & on behalf of the ESC Study Group of Sports Cardiology. (2006). ESC Study Group of Sports Cardiology Position Paper on adverse cardiovascular effects of doping in athletes. European Journal of Cardiovascular Prevention & Rehabilitation. https://doi.org/10.1097/01.hjr.0000224482.95597.7a

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.